Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Asthma
56%
Patient
48%
Latent Tuberculosis
37%
Therapeutic Procedure
34%
Human Adenovirus C
31%
Respiratory Tract Inflammation
26%
Chronic Bronchitis
26%
Lung Cancer
25%
Tuberculosis
21%
Awareness
21%
Airway Remodeling
21%
Lung Function Test
20%
Prevalence
20%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
19%
Lung
19%
Pneumonia
17%
Forced Expiratory Volume
17%
Patient with Asthma
16%
Screening
16%
Pathogen
16%
Non Small Cell Lung Cancer
16%
Organoid
15%
Bone Marrow Derived Mesenchymal Stem Cell
15%
Inpatient
14%
Cohort Analysis
14%
Disease Exacerbation
14%
Tuberculosis
14%
Respiratory Failure
13%
Respiratory Disease
12%
Cytokine
12%
Bronchodilating Agent
12%
Diagnosis
12%
Diabetes
12%
Forced Vital Capacity
11%
Symptom
11%
High Risk Population
11%
Pleura Effusion
10%
Oxygen Consumption
10%
Eosinophilia
10%
Influenza Vaccination
10%
Diabetes Mellitus
10%
Retrospective Cohort Study
10%
Adipose Tissue
10%
Sensitivity Analysis
10%
Interstitial Lung Disease
10%
Lung Lavage
10%
Cytomegalovirus
10%
Airway Obstruction
8%
Smoking
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
74%
Asthma
29%
Lung Cancer
26%
Respiratory Tract Inflammation
21%
Infectious Agent
15%
Latent Tuberculosis
15%
Infection
14%
Cytokine
14%
Disease Exacerbation
12%
Mouse Model
11%
Asthma
11%
Non Small Cell Lung Cancer
11%
Bronchodilating Agent
11%
Allergic Asthma
11%
Latent Tuberculosis
10%
Airway Remodeling
10%
Respiratory Tract Inflammation
10%
Tuberculosis
9%
Symptom
9%
Cohort Study
8%
Neoplasm
7%
Respiratory Tract Allergy
7%
Inflammation
7%
High-Throughput Screening
7%
Ovalbumin
7%
Interleukin 33
7%
Gamma Interferon
7%
Biological Marker
6%
Bronchiectasis
6%
Obstruction
6%
Inflammation
6%
Prevalence
6%
Thymic Stromal Lymphopoietin
5%
Thymic Stromal Lymphopoietin
5%
Airway Obstruction
5%
Emphysema
5%
Protein Tyrosine Kinase Inhibitor
5%
Anaplastic Lymphoma Kinase
5%
Interstitial Lung Disease
5%
microRNA 21
5%
Cidofovir
5%
Mycobacterium Tuberculosis
5%
Antagomir
5%
Diabetes Mellitus
5%
Influenza
5%
Loeffler Pneumonia
5%
Diabetes Mellitus
5%
Allergic Asthma
5%
Pneumonia
5%
Resistin
5%
Immunology and Microbiology
Asthma
23%
Thymic Stromal Lymphopoietin
21%
Airway
21%
Forced Expiratory Volume
18%
Infectious Agent
15%
Inflammation
15%
Forced Vital Capacity
13%
Lung Function
13%
Blood Level
12%
Interleukin 33
12%
Interleukin 25
12%
Allergic Asthma
11%
Allergic Asthma
11%
Bronchodilator
11%
Cytokine
10%
Acute Bronchitis
10%
Allergic Inflammation
10%
Respiratory Tract Allergy
9%
Prevalence
8%
Asthma
7%
Exercise
6%
Cytokine
6%
Liquid
5%
Molecule
5%
Mouse Model
5%
Bone Marrow
5%
Airflow
5%
Computer Assisted Tomography
5%
Pseudomonas aeruginosa
5%
Bone Marrow Derived Mesenchymal Stem Cell
5%
Real-Time Polymerase Chain Reaction
5%
High Risk Population
5%
Splenocyte
5%
Nontuberculosis Mycobacterium
5%
Severe Asthma
5%
X Ray
5%
Bone Marrow Derived Mesenchymal Stem Cell
5%
Receptor Potential
5%
Resistin
5%
Cytomegalovirus
5%
Population
5%
Adipose Tissue
5%
Resistin
5%
Inflammatory Cytokine
5%
Human Adenovirus C
5%
